Fuso Pharmaceutical Industries,Ltd.

Tokyo Stock Exchange 4538.T

Fuso Pharmaceutical Industries,Ltd. Total Non-Current Liabilities for the year ending March 31, 2024: USD 67.02 M

Fuso Pharmaceutical Industries,Ltd. Total Non-Current Liabilities is USD 67.02 M for the year ending March 31, 2024, a 6.73% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Fuso Pharmaceutical Industries,Ltd. Total Non-Current Liabilities for the year ending March 31, 2023 was USD 62.80 M, a -9.30% change year over year.
Fuso Pharmaceutical Industries,Ltd. Total Non-Current Liabilities for the year ending March 31, 2022 was USD 69.24 M, a -18.68% change year over year.
Fuso Pharmaceutical Industries,Ltd. Total Non-Current Liabilities for the year ending March 31, 2021 was USD 85.14 M, a -17.89% change year over year.
Fuso Pharmaceutical Industries,Ltd. Total Non-Current Liabilities for the year ending March 31, 2020 was USD 103.69 M, a -7.41% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

Tokyo Stock Exchange: 4538.T

Fuso Pharmaceutical Industries,Ltd.

CEO	Mr. Mikio Toda
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-7-10, Doshomachi
Employees	1,370
Sector	Consumers Staples
Industries Cleaning Supplies Automotive Parts Composite Materials Hardware & Electronics Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics

Description

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.

Key trends

Past 5 years